Reforgene passes intellectual property management system certification

Recently, Guangzhou Reforgene Medicine Co., Ltd. ("Reforgene") successfully passed the on-site audit certification of its intellectual property management system and obtained the "Intellectual Property Management System Certification", marking a new step for the company in the standardized management of intellectual property.

Passing the intellectual property management system certification is recognition of the company's intellectual property management work, covering the management of intellectual property related to the development of cell and gene medicines and their delivery technologies, and gene editing technologies.

As a leading innovative gene editing medicine enterprise, Reforgene has always adhered to independent innovation and attaches great importance to the creation, application, protection and management of intellectual property. We will take this as an opportunity to continue relying on our independent innovation R&D capability and intellectual property system advantages to provide strong support and guarantee for innovative development.

About the intellectual property management system

The certification of the intellectual property management system is mainly based on the Enterprise Intellectual Property Management Specification (GB/T29490-2013), which was formulated by the National Intellectual Property Administration and approved, promulgated and implemented by the General Administration of Quality Supervision, Inspection and Quarantine and the Standardization Administration of China. It is China's first national standard for enterprise intellectual property management. The specification aims to guide enterprises to establish a scientific, systematic and standardized intellectual property management system, effectively improving the contribution of intellectual property to enterprise operation and development.